Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00272324Phase 3Completed
Phase 3, randomised, double-blind trial of aspirin and folic acid in Colorectal Adenoma (CRA) (6 arms), sponsored by Dartmouth Health. Primary endpoint: Proportion of subjects with 1 or more recurrent adenomas at 8 years. Started Feb 1992; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00272324.